Navigation Links
Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index
Date:6/22/2009

CHENGDU, China, June 22 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it is set to join the Russell Microcap(R) Index when, according to a preliminary list of additions posted on June 12, 2009 at http://www.russell.com , Russell Investments ("Russell") reconstitutes its comprehensive set of U.S. and global equity indexes on June 26, 2009.

Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May 2009, ranking them by total market capitalization. Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

"We are very pleased to be selected for the Russell Indexes," stated Dr. Guoqing Jiang, Tianyin's Chief Executive Officer. "We believe inclusion in these indexes will help increase our visibility among investors and contribute to our efforts to increase liquidity and shareholder value."

The Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $4 trillion in assets currently are benchmarked to them. Total returns data for the Russell 3000 and other Russell indexes are available at http://www.russell.com/Indexes/performance/default.asp .

About Tianyin Pharmaceuticals

Tianyin is a m
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2010 Guidance
2. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Third Quarter Earnings Conference Call on Friday, May 15, 2009 at 11:00 a.m. EDT
4. Tianyin Pharmaceutical Co. Inc.s Ginkgo Mihuan Oral Solution Completes 2009 Tenders
5. Tianyin Pharmaceutical Co., Inc. Series A Preferred Shareholders Approved Cash Dividend to Common Stockholders
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2009 Financial Results
8. Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program
9. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 First Quarter Earnings Conference Call on Tuesday, November 11, 2008 at 8:30 a.m. EST
10. Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program
11. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...4 The American Associat...plauds the Senate for ensuring that the Community... remain in the final health reform legislation . T...pport to elders, people with disabilities and thei...health care reform bill that will make it affordab...
(Date:12/4/2009)...., Dec. 4 Pamela Bowen, Chief Info...ed as a finalist for the "Chief Innovation Officer...with the power of cloud computing. Appy Award reci...ge of Salesforce CRM or the Force.com platform in ...ales, marketing, partner, service, support or IT o...
(Date:12/4/2009)...A new study shows that muscle cells grown in the l...hut properly. The work, performed in dogs and rats...ions such as gastric reflux and fecal incontinence...incters, which are the bands of muscle that separa...akness in these areas can cause gastrointestinal e...
(Date:12/4/2009)... that men can be bastards and women must wear pear...he answer, according to an article in the Journal...al expressions. , In two studies, researchers as...ces. In the first study, androgynous faces with lo...were more likely to be identified as male, and fac...
(Date:12/4/2009)...from federal regulators to crack down on abuse of ...ealthDay News) -- The makers of 24 different presc...gulators with plans to curb the abuse of these opi... been under pressure from U.S. Food and Drug Admin...reds of fatal overdoses that occur with these medi...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
...y Nutritional,Foods (OTC Bulletin Board: GXYF), a ...ves, organic dairy and other organic and natural f... investor conference call to,discuss operating res...efore the market opens the same day., Shareholder...
... of the worlds greatest public health triumphs, bu...e best efforts of scientists to develop effective ...f how the immune system operates during a viral in...rt of the National Institutes of Health (NIH), hav...
...eek restatement of Beth Israel Deaconess,Medical C...O and,director Robert Lepofsky should apply the sa...er publicly traded companies to his role as Vice,C...ed Healthcare Workers East., 1199 SEIU asserts th...
...cost increases for,employers throughout the world ...s, according to a poll of insurance companies cond...consulting firm. The poll also found,that, in a va...t higher or,significantly higher medical cost tren...
... salt levels in foods and,beverages are on the min...,and beverage industry. Why? In two words -- healt... Market Trend: Low, Reduced or No Sodium or Salt,F...ch have been argued as contributing to the record ...
...Limited, BOSTON, Feb. 6 Patient-Centered Computi...s an innovative and timely,course that will be pre...l,s Division of Continuing Education. The course, ...ttendees from,throughout the United States, and ab...
Other Medicine News:Health News:Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008 2Health News:Researchers discover new battleground for viruses and immune cells 2Health News:Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News:Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds 2Health News:Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds 3Health News:Sodium Content Foods and Beverages Gain Revenues as Americans are Embracing Low- and No-Sodium Campaigns 2Health News:Innovative eHealth Course to Take Place March 28-30 in Boston, Massachusetts 2
(Date:12/4/2009)... , WINSTON-SALEM, N.C., Dec. 4 /PRNewswire-USNe...grant will support researchers at the University o...ators at Wake Forest University as they study why ...ver time and how to address the problem. This "sto...ciated with increased risk for cardiovascular even...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -...s volume changes in the size of suspicious nodules...ut non-cancerous ones with almost perfect accuracy...fewer, less expensive and less invasive tests. ,...81016/LCALOGO ) ,, The new diagnostic guideline...
(Date:12/4/2009)... , INDIANAPOLIS, Dec. 4 /PRNewswire-FirstCal...) today approved Zyprexa® (olanzapine) in tab...hrenia and manic or mixed episodes associated with...s old. ,, The updated Zyprexa label states tha...creased potential for weight gain and hyperlipidem...
Breaking Medicine Technology:NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech 3B Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning 12784 1Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech 3B Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning 12784 2Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech 3B Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning 12784 3Obese Poor Shut Out From Weight Loss Surgeries 50027 1Obese Poor Shut Out From Weight Loss Surgeries 50027 2Obese Poor Shut Out From Weight Loss Surgeries 50027 3Obese Poor Shut Out From Weight Loss Surgeries 50027 4PatientAssistance com Releases the Top 20 Most Popular Searches for Patient Assistance Programs 50025 1PatientAssistance com Releases the Top 20 Most Popular Searches for Patient Assistance Programs 50025 2PatientAssistance com Releases the Top 20 Most Popular Searches for Patient Assistance Programs 50025 3
...er Patients With Improved Potential,to Battle Thei...swire-FirstCall/ --,Arrowhead Research Corporation...bsidiaries, Insert Therapeutics Inc. and Calando,P...07 American,Association for Cancer Research (AACR)...atest research findings on two,anticancer therapie...
...Apr 16, 2007 - Introgen Therapeutics,Inc. (NASDAQ...over,the weekend in Los Angeles, California at the...ncer Research., Abnormality of the p53 tumor suppr...lecular defects in cancer. ADVEXIN,s,mechanism of ...or,function and the detection of abnormal p53 is a...
Other Medicine Technology:Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 2Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 3Arrowhead Subsidiaries Insert & Calando Present Data on,Cyclosert Drug Delivery System at AACR Meeting 4Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 2Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 3Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference 4
ThermoFlo™ Filter
Clear-Guard Midi™
...e has the right product for any patient ranging fr...s to patients with tracheotomies. These products o...nd critical care applications., ,The Unti-Mist HM...atients and staff members. This entire product lin...
30303 Filter
Medicine Products: